IMMUNITYBIO, INC. APIC, Share-based Payment Arrangement, Recognition and Exercise
IMMUNITYBIO, INC. (IBRX) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of -$321.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2020-11-09
- IMMUNITYBIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2020-09-30 was -$321.00K.
- IMMUNITYBIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2020-06-30 was -$40.00K.
- IMMUNITYBIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2020-03-31 was -$123.00K.
- IMMUNITYBIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2019-09-30 was -$40.00K.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month |
|---|---|---|---|
| 2020-09-30 | -$321.00K 10-Q · filed 2020-11-09 | -$361.00K derived: sum of 2 quarters · filed 2020-11-09 | -$485.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$40.00K 10-Q · filed 2020-08-07 | -$163.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$123.00K 10-Q · filed 2020-05-11 | ||
| 2019-09-30 | -$40.00K 10-Q · filed 2020-11-09 | -$40.00K derived: sum of 2 quarters · filed 2020-11-09 | -$66.00K 10-Q · filed 2020-11-09 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-07 | -$26.00K 10-Q · filed 2020-08-07 | |
| 2019-03-31 | -$26.00K 10-Q · filed 2020-05-11 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$50.00K derived: sum of 2 quarters · filed 2018-11-07 | -$123.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$123.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | -$73.00K 10-Q · filed 2019-05-08 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$9.00K derived: sum of 2 quarters · filed 2017-11-07 | -$709.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$709.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | -$700.00K 10-Q · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |